(Q55030892)

English

Urolithin A, C, and D, but not iso-urolithin A and urolithin B, attenuate triglyceride accumulation in human cultures of adipocytes and hepatocytes.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 June 2018

http://europepmc.org/abstract/MED/26872561

Urolithin A, C, and D, but not iso-urolithin A and urolithin B, attenuate triglyceride accumulation in human cultures of adipocytes and hepatocytes. (English)

1 reference

Europe PubMed Central

15 June 2018

http://europepmc.org/abstract/MED/26872561

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Juan Carlos Espín

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26872561%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Francisco A Tomas-Barberan

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26872561%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26872561%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Inhae Kang

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26872561%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

YongEun Kim

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26872561%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

publication date

13 April 2016

1 reference

Europe PubMed Central

15 June 2018

http://europepmc.org/abstract/MED/26872561

Molecular Nutrition and Food Research

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26872561%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

60

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26872561%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26872561%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

1129-1138

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26872561%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Reduction of oxidative stress and apoptosis in hyperlipidemic rabbits by ellagic acid

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Dietary ellagic acid attenuates oxidized LDL uptake and stimulates cholesterol efflux in murine macrophages

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

In vitro anti-proliferative activities of ellagic acid

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Ellagic acid attenuates high-carbohydrate, high-fat diet-induced metabolic syndrome in rats.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Evidence of anti-obesity effects of the pomegranate leaf extract in high-fat diet induced obese mice.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Ellagic acid inhibits adipocyte differentiation through coactivator-associated arginine methyltransferase 1-mediated chromatin modification

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Ellagic acid modulates lipid accumulation in primary human adipocytes and human hepatoma Huh7 cells via discrete mechanisms

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Time course production of urolithins from ellagic acid by human gut microbiota.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Biological significance of urolithins, the gut microbial ellagic Acid-derived metabolites: the evidence so far

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Phase-II metabolism limits the antiproliferative activity of urolithins in human colon cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Pomegranate ellagitannin-derived compounds exhibit antiproliferative and antiaromatase activity in breast cancer cells in vitro

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Antiglycative and neuroprotective activity of colon-derived polyphenol catabolites

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Urolithins, intestinal microbial metabolites of Pomegranate ellagitannins, exhibit potent antioxidant activity in a cell-based assay

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Improved detection of long-chain fatty acid oxidation defects in intact cells using [9,10-3H]oleic acid

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Rubi Fructus (Rubus coreanus) Inhibits Differentiation to Adipocytes in 3T3-L1 Cells

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Dieckol, a major phlorotannin in Ecklonia cava, suppresses lipid accumulation in the adipocytes of high-fat diet-fed zebrafish and mice: Inhibition of early adipogenesis via cell-cycle arrest and AMPKα activation

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

AMPK: a nutrient and energy sensor that maintains energy homeostasis

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Gene expression, cell cycle arrest and MAPK signalling regulation in Caco-2 cells exposed to ellagic acid and its metabolites, urolithins.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Urolithins, gut microbiota-derived metabolites of ellagitannins, inhibit LPS-induced inflammation in RAW 264.7 murine macrophages

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

The gut microbiota as an environmental factor that regulates fat storage

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Mechanisms underlying the resistance to diet-induced obesity in germ-free mice

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

An obesity-associated gut microbiome with increased capacity for energy harvest

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

The human gut microbial ecology associated with overweight and obesity determines ellagic acid metabolism

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Description of urolithin production capacity from ellagic acid of two human intestinal Gordonibacter species

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Intestinal microbiota in metabolic diseases: from bacterial community structure and functions to species of pathophysiological relevance

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Iberian pig as a model to clarify obscure points in the bioavailability and metabolism of ellagitannins in humans.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Chemopreventive activity of ellagitannins and their derivatives from black raspberry seeds on HT-29 colon cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Membrane and nuclear estrogen receptor α collaborate to suppress adipogenesis but not triglyceride content

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Inhibition of N-nitrosobenzylmethylamine metabolism and DNA binding in cultured rat esophagus by ellagic acid

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Ellagic acid binding to DNA as a possible mechanism for its antimutagenic and anticarcinogenic action.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Ellagic Acid Reduces Adipogenesis through Inhibition of Differentiation-Prevention of the Induction of Rb Phosphorylation in 3T3-L1 Adipocytes

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Punicalagin, an active component in pomegranate, ameliorates cardiac mitochondrial impairment in obese rats via AMPK activation

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Ellagic Acid Metabolism by Human Gut Microbiota: Consistent Observation of Three Urolithin Phenotypes in Intervention Trials, Independent of Food Source, Age, and Health Status

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Targeted metabolic profiling of pomegranate polyphenols and urolithins in plasma, urine and colon tissues from colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Chromatographic and spectroscopic characterization of urolithins for their determination in biological samples after the intake of foods containing ellagitannins and ellagic acid

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Identifying the limits for ellagic acid bioavailability: A crossover pharmacokinetic study in healthy volunteers after consumption of pomegranate extracts

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201500796

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55030892&oldid=1277444378"